GO
Loading...

U.S. Regulators OK Generic Version Of Ambien Sleeping Pill

Mylan Laboratories said U.S. regulators approved its generic version of Sanofi-Aventis' sleeping pill, Ambien, in the 5 mg and 10 mg strengths.

In a statement, the generic drug maker said the product is being shipped immediately.

Ambien had sales of about $2.2 billion in the U.S. for the same strengths for the 12-month period ending Dec. 31, 2006, according to IMS Health.

Sanofi-Aventis lost patent protection for Ambien on April 21. Ambien dominates the U.S. sleeping pill market, which is growing at about 10% a year.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • With the World Series beginning tonight in Kansas City, Zach Marten, co-owner of the Westport Ale House, discusses the lift Kansas City businesses are getting.

  • Israel's main stock index is up more than 10 percent this year. Yossi Beinart, Tel Aviv Stock Exchange CEO, discusses what sectors are powering the Tel Aviv index.

  • "Street Signs" hosts Mandy Drury and Brian Sullivan look at 5 stocks with 5 analyst recommendations, including a bullish call on Halliburton and an upgrade for Post Holdings.